---
title: "Ascentage Pharma Says Underwriters Exercise Option to Buy Additional American Depositary Shares"
date: "2025-02-07 22:20:06"
summary: "Ascentage Pharma said Friday that underwriters of its US initial public offering have partially exercised an over-allotment option to buy an additional 935,144 American depositary shares at the IPO price of $17.25 per ADS. After the partial exercise of the over-allotment option, the total number of ADSs sold in the..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Ascentage Pharma said Friday that underwriters of its US initial public offering have partially exercised an over-allotment option to buy an additional 935,144 American depositary shares at the IPO price of $17.25 per ADS.

After the partial exercise of the over-allotment option, the total number of ADSs sold in the offering will rise to about 8.3 million ADSs and the gross proceeds will be about $142.5 million, the biopharmaceutical company said.

AAPG shares were over 2% higher ahead of Friday's opening bell.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3312568:0/)
